Financials data is unavailable for this security.
View more
Year on year CI Medical Co Ltd 's net income fell -17.37% from 2.52bn to 2.08bn despite revenues that grew 6.38% from 42.89bn to 45.63bn. An increase in the selling, general and administrative costs as a percentage of sales from 17.88% to 19.67% was a component in the falling net income despite rising revenues.
| Gross margin | 25.73% |
|---|---|
| Net profit margin | 3.06% |
| Operating margin | 4.48% |
| Return on assets | 3.55% |
|---|---|
| Return on equity | 7.23% |
| Return on investment | 7.19% |
More ▼
Cash flow in JPYView more
In 2023, CI Medical Co Ltd did not generate a significant amount of cash. Cash Flow from Financing totalled 9.83bn or 21.53% of revenues. In addition the company used 139.00m for operations while cash used for investing totalled 9.80bn.
| Cash flow per share | 67.08 |
|---|---|
| Price/Cash flow per share | 15.65 |
| Book value per share | 408.47 |
|---|---|
| Tangible book value per share | 376.27 |
More ▼
Balance sheet in JPYView more
| Current ratio | 0.8935 |
|---|---|
| Quick ratio | 0.524 |
| Total debt/total equity | 0.9404 |
|---|---|
| Total debt/total capital | 0.4835 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -17.41%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.53% |
|---|---|
| Div growth rate (5 year) | 13.65% |
| Payout ratio (TTM) | 17.59% |
| EPS growth(5 years) | 9.38 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -35.42 |
More ▼
